CPC
COMPANY PROFILES
AND
CONFERENCES
 
 Welcome Guest

Currency:  Euro Dollor Pound  |  Cart  ( 0 ) items in cart
   
Search
Advanced search
 
BROWSE INDUSTRY


SignUp


Home Back Research Index Back Medical Devices Back Endologix, Inc. (ELGX) - Product Pipeline Analysis

Endologix, Inc. (ELGX) - Product Pipeline Analysis

Enquire | Email | Print

 
Format PDF
ISBN GDME92PD
Published Date June 2014
No. of Pages 41
Select pricing :
Change Currency : EURO | $ USD | £ GBP
 
Bookmark and Share
 
Description
 
  • Abstract
  • Table of Contents

Summary

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its products are built on one of the two platforms, namely, traditional minimally-invasive endovascular repair (EVAR) or endovascular sealing (EVAS). The company’s EVAR products include AFX Endovascular AAA System and Intuitrak Endovascular AAA System; and EVAS products comprise Nellix Endovascular Aneurysm Sealing System. The company sells its ELG system to hospitals in the US, Europe, and to third-party international distributors. It has manufacturing facility in Irvine. Endologix is headquartered in California, the US.

Endologix seeks to obtain expanded US FDA clearances and approvals in order to achieve market acceptance for its products. The company focuses on the expansion of its product portfolio by building a strong operating base, besides gaining expertise through agreements and collaborations.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Endologix, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Endologix, Inc. Company Snapshot 6
Endologix, Inc. Company Overview 6
Key Information 6
Endologix, Inc. Pipeline Products and Clinical Trials Overview 7
Endologix, Inc. – Pipeline Analysis Overview 9
Business Description 9
Key Facts 10
Endologix, Inc. - Major Products and Services 11
Endologix, Inc. Pipeline Products by Development Stage 12
Endologix, Inc. Clinical Trials by Trial Status 14
Endologix, Inc. Pipeline Products Overview 16
AFX 16
AFX Product Overview 16
AFX Clinical Trial 17
AFX3 18
AFX3 Product Overview 18
AFX4 19
AFX4 Product Overview 19
Bariatric Stent 20
Bariatric Stent Product Overview 20
Nellix EndoVascular Aneurysm Sealing System 21
Nellix EndoVascular Aneurysm Sealing System Product Overview 21
Nellix EndoVascular Aneurysm Sealing System Clinical Trial 22
Nellix2 AAA Endovascular System 24
Nellix2 AAA Endovascular System Product Overview 24
VELA Proximal Endograft System 25
VELA Proximal Endograft System Product Overview 25
Ventana 2 26
Ventana 2 Product Overview 26
Ventana Fenestrated Stent Graft 27
Ventana Fenestrated Stent Graft Product Overview 27
Ventana Fenestrated Stent Graft Clinical Trial 28
Xpand BX Covered Stent 30
Xpand BX Covered Stent Product Overview 30
Endologix, Inc. - Key Competitors 31
Endologix, Inc. - Key Employees 32
Endologix, Inc. - Key Employee Biographies 33
Endologix, Inc. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Endologix, Inc., Recent Developments 35
Jun 17, 2014: Endologix Achieves Revenue Milestone for the Nellix EndoVascular Aneurysm Sealing System 35
Apr 30, 2014: Endologix Reports 12% Global Revenue Growth for the First Quarter 2014 35
Apr 29, 2014: Endologix Inc. Partners With Terso Solutions, Inc. For Fully Automated Nellix Inventory At Medical Facilities Worldwide 36
Feb 27, 2014: Endologix Reports 25% and 21% Revenue Growth for the Full Year and Fourth Quarter 2013 36
Feb 10, 2014: Endologix Announces US Launch Of VELA Proximal Endograft System 38
Jan 21, 2014: Endologix Announces Enrollment of First Patient in EVAS FORWARD-IDE Clinical Trial 38
Jan 06, 2014: Endologix to Present at the 32nd Annual J.P. Morgan Healthcare Conference 39
Dec 20, 2013: Endologix Receives IDE Approval for the Nellix EndoVascular Aneurysm Sealing System 39
Nov 25, 2013: Endologix to Participate in Two Investor Conferences in December 39
Nov 21, 2013: Endologix, Inc. to ring The Nasdaq Stock Market opening bell 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables

Endologix, Inc., Key Facts 6
Endologix, Inc. Pipeline Products and Clinical Trials Overview 7
Endologix, Inc. Pipeline Products by Equipment Type 7
Endologix, Inc. Pipeline Products by Indication 8
Endologix, Inc. Clinical Trials by Trial Status 8
Endologix, Inc., Key Facts 10
Endologix, Inc., Major Products and Services 11
Endologix, Inc. Number of Pipeline Products by Development Stage 12
Endologix, Inc. Pipeline Products Summary by Development Stage 13
Endologix, Inc. Clinical Trials by Trial Status 14
Endologix, Inc. Clinical Trials Summary 15
AFX - Product Status 16
AFX - Product Description 16
AFX - Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic Aneurysms: An Investigator-Initiated Study 17
AFX3 - Product Status 18
AFX3 - Product Description 18
AFX4 - Product Status 19
AFX4 - Product Description 19
Bariatric Stent - Product Status 20
Bariatric Stent - Product Description 20
Nellix EndoVascular Aneurysm Sealing System - Product Status 21
Nellix EndoVascular Aneurysm Sealing System - Product Description 21
Nellix EndoVascular Aneurysm Sealing System - A Pivotal Clinical Trial To Evaluate the Safety and Effectiveness of the Nellix EndoVascular Aneurysm Sealing System ("EVAS") For The Endovascular Repair 22
Nellix EndoVascular Aneurysm Sealing System - Multicenter, Observational, Post-Market, Real World Registry to Assess Outcomes of Patients Treated With the Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 22
Nellix EndoVascular Aneurysm Sealing System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System 22
Nellix EndoVascular Aneurysm Sealing System - The Nellix EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms 23
Nellix2 AAA Endovascular System - Product Status 24
Nellix2 AAA Endovascular System - Product Description 24
VELA Proximal Endograft System - Product Status 25
VELA Proximal Endograft System - Product Description 25
Ventana 2 - Product Status 26
Ventana 2 - Product Description 26
Ventana Fenestrated Stent Graft - Product Status 27
Ventana Fenestrated Stent Graft - Product Description 27
Ventana Fenestrated Stent Graft - Emory the Only Site in Georgia for Trial of New Branched Aortic Stent Graft 28
Ventana Fenestrated Stent Graft - Pilot Study Of The Ventana Fenestrated Stent Graft As A New Aortic Extension Designed To Be Used With The Anatomically-Fixed Powerlink Bifurcated Stent Graft 28
Ventana Fenestrated Stent Graft - Prospective, Multicenter, Single Arm Feasibility and Initial Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 29
Ventana Fenestrated Stent Graft - Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 29
Ventana Fenestrated Stent Graft - Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 29
Xpand BX Covered Stent - Product Status 30
Xpand BX Covered Stent - Product Description 30
Endologix, Inc., Key Employees 32
Endologix, Inc., Key Employee Biographies 33
Endologix, Inc., Subsidiaries 34

List of Figures

Endologix, Inc. Pipeline Products by Equipment Type 7
Endologix, Inc. Pipeline Products by Development Stage 12
Endologix, Inc. Clinical Trials by Trial Status 14


Related reports
  

Adaptive Biotechnologies Corporation - Product Pipeline Analysis

  

Akonni Biosystems, Inc. - Product Pipeline Analysis

  

Alfa Wassermann, Inc. - Product Pipeline Analysis

  

AnalizaDx, LLC - Product Pipeline Analysis

  

ARK Diagnostics, Inc. - Product Pipeline Analysis

  

Astute Medical, Inc. - Product Pipeline Analysis

  

Atlas Genetics Ltd. - Product Pipeline Analysis


Bookmark With : Facebook Blogger MySpace Twitter Del.icio.us Reddit Furl WordProcess
 
Custom Research
If above report does not meet your requirements then you may avail our custom research service. We provide the most comprehensive, affordable, high-quality custom research which will match the exact topic and specifications of your choice. Please visit our Custom Research page to make an enquiry.
 
Product Id : 7085
INR 46173.45
GlobalData
 


RECENTLY VIEWED
 Endologix, Inc. (ELGX) - Product Pipeline Analysis
 
We accept
Master Card Visa
Amex Discover
Paypal Diners Club
Mob +919223375060 / 919223767111
Fax: +91 22 27810778
E-mail:info@companyprofilesandconferences.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST